A key driver of #MASLD is excess free faty acid supply from #adipose tissue. #Lipodystrophy is a unique disorder where adipose tissue is deficient. People with Partial LD still have marked #InsulinResistance and #FattyLiver. What can we learn by (3/n) h
@drkeithsiau Nice. Lipodystrophy syndromes should be considered as well https://t.co/KbDexLYn9n
RT @EndocrinoHUVR: No tratamiento específico Papel de #Leptina? Más en lipodistrofia generalizadas #Diabetes ▪️Metformina: primera lín…
@raphaels7 is lipodystrophy not defined as “disorders of deficient body fat” hence patients exceed their PFT easily? Brown (2016) https://t.co/GqSKUnllEN
RT @EndocrinoHUVR: No tratamiento específico Papel de #Leptina? Más en lipodistrofia generalizadas #Diabetes ▪️Metformina: primera lín…
Se Dunningan. Metreleptina.
No tratamiento específico Papel de #Leptina? Más en lipodistrofia generalizadas #Diabetes ▪️Metformina: primera línea (Clase IIa, Nivel C) ▪️Insulina: efectiva pero altas dosis (Clase IIa, Nivel C) ▪️Tiazolidindionas https://t.co/oLm65yfSf1
Consensus Statement: The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline https://t.co/875mTiRXHt
Consensus Statement: The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline https://t.co/875mTiRXHt
RT @ICAN_Institute: #Diagnosis & #management of #lipodystrophy syndromes: a multi-society practice #guideline https://t.co/CjhTezflAA #lipi…
#Diagnosis & #management of #lipodystrophy syndromes: a multi-society practice #guideline https://t.co/CjhTezflAA #lipid #fat #doctor
RT @mbotana: Guía lipodistrofias. Elaborada con otros por nuestro compañero David Araúxo. @SoGENM @cristinatejerap @DiegoBellido2 https://t…
RT @mbotana: Guía lipodistrofias. Elaborada con otros por nuestro compañero David Araúxo. @SoGENM @cristinatejerap @DiegoBellido2 https://t…
Guía lipodistrofias. Elaborada con otros por nuestro compañero David Araúxo. @SoGENM @cristinatejerap @DiegoBellido2 https://t.co/szQsBkZFy3
RT @DanielJDrucker: #personalizedmedicine Dx & Management of #Lipodystrophy Syndromes: A Multi-Society Practice Guideline: @EndoMedia…
RT @DanielJDrucker: #personalizedmedicine Dx & Management of #Lipodystrophy Syndromes: A Multi-Society Practice Guideline: @EndoMedia…
#personalizedmedicine Dx & Management of #Lipodystrophy Syndromes: A Multi-Society Practice Guideline: @EndoMedia https://t.co/CdxC8gncoH https://t.co/aAHdSNBXLM